Zoetis misidentified vials of the injectable vaccine for cats as ‘intranasal’
Zoetis has recalled an untold amount of Vanguard Feline RCP due to a packaging error that mislabeled vials of the injectable vaccine by listing “intranasal” as the route of administration.
“This product is only approved for subcutaneous or intramuscular injectable administration in felines,” company officials confirmed in a statement to the VIN News Service. The vaccine is intended to protect cats against feline herpesvirus-1, feline calicivirus and feline parvovirus.
Zoetis is asking all veterinarians who have received mislabeled product to return it to the company. Officials will start contacting distributors and veterinary practices next week with steps for returning product and receiving replacements, “rounded up to the next full tray,” the statement reads. Customers with immediate questions can call Zoetis at (888) 963-8471.
As of Thursday afternoon, the recall had not been announced on the company’s website.
Veterinarians say it’s a big deal if cats inhale vaccines that are meant to be injected.
Dr. Elizabeth Coney of Lexington, Kentucky, reported the label discrepancy on Tuesday in a message board post on the Veterinary Information Network, an online community for the profession and parent of the VIN News Service. She said that the outer package containing a tray of Vanguard Feline RCP lists the vaccines as “injectable,” while the individual vials are labeled “intranasal.”
“This is dangerous,” she wrote. “Already had a fellow DVM wonder if this mislabeled product could be given either SQ [subcutaneous] or IN [intranasal].”
[image: Dr. Elizabeth Coney]